PUBLISHER: Polaris Market Research | PRODUCT CODE: 1259816
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1259816
The global bone growth stimulator market size is expected to reach USD 3.33 billion by 2032, according to a new study by Polaris Market Research. The report "Bone Growth Stimulator Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Application; By End-Use (Hospital & Ambulatory Surgical Centers, Home care, Academic and Research Institutes, Others); By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The bone growth stimulators market is experiencing growth primarily due to several key factors, including the increasing aging population, a rise in the incidence of fractures and accidents, a growing prevalence of arthritis, an increase in the number of cases of medical conditions like diabetes, obesity, vascular disease, and renal disorders. The trend toward minimally non-invasive and invasive surgical treatments also contributes to the market's growth. All these factors are expected to continue to drive the growth of the bone growth stimulators market in the coming years.
In addition, the market's overall growth is driven by technological advancements, increasing investment in research and development, and the growing demand for non-invasive treatment options.
In recent years, advancements in bone growth stimulation technology have increased the adoption of bone growth stimulators in several segments. This trend is expected to continue as more patients seek minimally invasive surgical procedures, and the demand for bone growth stimulators grows.
The bone growth stimulation devices segment accounted for the highest revenue share due to the increasing prevalence of orthopedic conditions and sports injuries and the growing use of bone growth stimulation devices.
The spinal Fusion Surgeries segment dominated the market in 2022, mainly driven by a rising incidence of spinal disorders, such as degenerative disc disease and spinal stenosis, which is driving the growth of the spinal fusion surgeries segment.
The hospital & ambulatory surgical centers segment held a significant market share and is likely to continue its dominance over the anticipated period due to the increasing demand for minimally invasive surgeries and the cost-effectiveness of outpatient procedures.
North America accounted for the largest market share in 2022 and is likely to maintain its dominance over the projected period due to the presence of key market players, increasing healthcare expenditure, growing patient awareness, and increasing the number of bone disorders.
The global key market players include THERAGEN ETEX CO., LTD, Manamed Inc, Arthrex, Terumo Corporation, Orthofix Medical Inc., Essex Woodlands Healthcare Partners (Bioventus LLC), Isto Biologics, IGEA Pharma ZIMMER BIOMET HOLDINGS, MEDTRONIC PLC., DJO Global, STRYKER CORPORATION, JOHNSON, and JOHNSON.
Polaris Market Research has segmented the bone growth stimulator market report based on product type, application, end-use, and region:
Bone Growth Stimulator, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)
Bone Growth Stimulation Devices
External Bone Growth Stimulators
Ultrasonic Bone Growth Stimulators
Implanted Bone Growth Stimulators
Bone Morphogenetics Proteins
Platelet Rich Plasma
Bone Growth Stimulator, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Spinal Fusion Surgeries
Delayed union & Non-union Bone Fractures
Oral & Maxillofacial Surgeries
Others
Bone Growth Stimulator, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
Hospital & Ambulatory Surgical Centers
Home care
Academic and Research institutes
Others
Bone Growth Stimulator, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa